ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,522.40
1.05%
다우존스 지수
40,589.34
1.64%
Bitcoin
67,949.72
0.05%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) 뉴스

TTOO T2 Biosystems Inc

5.08
0.25 (5.18%)
27 7월(7) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
T2 Biosystems Inc TTOO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.25 5.18% 5.08 08:47:57
개장가 저가 고가 종가 전일 종가
4.82 4.75 5.14 5.09 4.83
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/07/202405:05GLOBET2 Biosystems to Report Second Quarter 2024 Financial..
20/07/202406:04EDGAR2Form S-3 - Registration statement under Securities Act of..
20/07/202405:16EDGAR2Form 8-K - Current report
25/06/202422:00GLOBET2 Biosystems Announces Commercial Expansion Through Hong..
05/06/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
25/05/202410:04EDGAR2Form S-3 - Registration statement under Securities Act of..
23/05/202405:49EDGAR2Form 8-K - Current report
22/05/202422:00GLOBET2 Biosystems Regains Compliance with Nasdaq Continued..
20/05/202420:00EDGAR2Form 8-K - Current report
18/05/202405:05GLOBET2 Biosystems Announces Closing of $8 Million Private..
15/05/202420:00GLOBET2 Biosystems Announces $8 Million Private Placement Priced..
15/05/202406:00GLOBET2 Biosystems Announces CRG’s Conversion from Preferred..
15/05/202405:55EDGAR2Form RW - Registration Withdrawal Request
15/05/202405:43EDGAR2Form 8-K - Current report
14/05/202408:21EDGAR2Form SC 13D/A - General statement of acquisition of..
14/05/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202408:46EDGAR2Form SC 13D/A - General statement of acquisition of..
08/05/202405:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202405:48EDGAR2Form 8-K - Current report
07/05/202422:00GLOBET2 Biosystems Announces Letter of Intent to Enter Strategic..
07/05/202406:27EDGAR2Form S-1/A - General form for registration of securities..
07/05/202406:24EDGAR2Form 8-K - Current report
07/05/202406:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/05/202405:34GLOBET2 Biosystems Announces First Quarter 2024 Financial Results
07/05/202405:34GLOBET2 Biosystems Announces Commercial Expansion Through Middle..
07/05/202405:29GLOBET2 Biosystems Announces the Conversion of an Additional $15..
06/05/202420:48EDGAR2Form S-1/A - General form for registration of securities..
24/04/202422:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
12/04/202405:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
28/03/202422:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20/03/202420:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
19/03/202422:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
18/03/202422:00GLOBET2 Biosystems Announces New Publication Highlighting the..
12/03/202422:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
05/03/202406:34EDGAR2Form DEF 14A - Other definitive proxy statements
28/02/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:00EDGAR2Form 8-K - Current report
16/02/202406:49EDGAR2Form PRE 14A - Other preliminary proxy statements
16/02/202406:47EDGAR2Form 8-K - Current report
16/02/202406:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
16/02/202406:04GLOBET2 Biosystems Announces Agreement with CRG for the..
16/02/202406:02GLOBET2 Biosystems Announces Commercial Expansion Through..
14/02/202410:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..

최근 히스토리

NASDAQ
TTOO
T2 Biosystems
USOTC
TPIA
Mycotopia Therapies (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유